Two new anticoagulants just hit the market

July 1997

Two new anticoagulants just hit the market...Normiflo (ardeparin) and Orgaran (danaparoid). They're both approved to prevent deep vein thrombosis after certain orthopedic surgeries.

Normiflo is a low molecular weight heparin...similar to Lovenox (enoxaparin) and Fragmin (dalteparin).

Low molecular weight heparins contain heparin fragments. They work at least as well as heparin...with less risk of bleeding.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

New recommendations for preventing bacterial endocarditis
Lyme Disease Ceftin (cefuroxime) for Lyme disease
Lyme Disease Vaccine to prevent Lyme disease
Asthma New OTC device called Doser
Diabetes New recommendations for DIAGNOSING diabetes
Diabetes New guidelines for TREATING type 2 diabetes
Women's Health Raloxifene (Evista), a new "designer estrogen"
Women's Health Risks and benefits of hormone replacement therapy
Laxatives The stimulant laxative phenolphthalein will probably be taken off the market
New HIV protease inhibitors might increase blood sugar
New guidelines for treating HIV
Info about vaccines and medicines needed for international travel
What to use to prevent motion sickness
Loading up on creatine to boost performance
Pyruvate to enhance fat loss and improve endurance
Anticoagulants Two new anticoagulants just hit the market
Anticoagulants Orgaran (danaparoid) contains a substance that's similar to heparin...Heparan
Chronotherapeutics is a hot area right now

Two new anticoagulants just hit the market

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents